The structure classifying the early psychosis using the clinician-rated dimensions of psychosis symptom severity in DSM-5: 1-year longitudinal cohort study

被引：0
|
作者：
Lee, K. [1 ]
Jaehoon, C. [1 ]
机构：
[1] Eulji Univ, Eulji Hosp, Psychiat, Seoul, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2019.09.409
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.395
引用
收藏
页码：S280 / S280
页数：1
相关论文
共 14 条
  • [1] Psychometric properties of the DSM-5 Clinician-Rated Dimensions of Psychosis Symptom Severity
    Berendsen, S.
    van der Veen, N. M.
    van Tricht, M. J.
    de Haan, L.
    SCHIZOPHRENIA RESEARCH, 2020, 216 : 416 - 421
  • [2] DSM-5 CLINICIAN-RATED DIMENSIONS OF PSYCHOSIS SYMPTOM SEVERITY: PSYCHOMETRIC PROPERTIES
    Liemburg, Edith
    Nienhuis, Fokko
    Veling, Wim
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S170 - S171
  • [3] THE CLINICAL IMPLICATION OF CLINICIAN-RATED DIMENSIONS OF PSYCHOSIS SYMPTOM SEVERITY (CRDPSS) FOR DIAGNOSIS BY DSM-5
    Nam, Beomwoo
    Bahk, Won-Myong
    Lee, Sang-Yeol
    Lee, Kwanghun
    Jon, Duk-In
    Lim, Eunsung
    Park, Sung-Yong
    Song, Min-Kyu
    Jo, Seongwoo
    Jeon, Youngsoon
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S367 - S368
  • [4] FACTOR STRUCTURE OF THE CLINICIAN-RATED DIMENSION OF PSYCHOSIS SYMPTOM SEVERITY IN PATIENTS WITH EARLY PSYCHOSIS
    Lee, Kyuyoung
    Kim, Yong Sik
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S180 - S180
  • [5] Factor Structure of the Clinician-Rated Dimensions of Psychosis Symptom Severity in Patients with Schizophrenia
    Park, Seon-Cheol
    Lee, Kang Uk
    Choi, Joonho
    PSYCHIATRY INVESTIGATION, 2016, 13 (02) : 253 - 254
  • [6] The factor structure and clinical utility of clinician-rated dimensions of psychosis symptom severity in patients with recent-onset psychosis: Results of a 1-year longitudinal follow-up prospective cohort study
    Jeong, Jae Hoon
    Kim, Sung-Wan
    Lee, Bong Ju
    Kim, Jung Jin
    Yu, Je-Chun
    Won, Seung-Hee
    Lee, Seung-Hwan
    Kim, Seung-Hyun
    Kang, Shi Hyun
    Kim, Euitae
    Chung, Young-Chul
    Lee, Kyu Young
    PSYCHIATRY RESEARCH, 2022, 310
  • [7] DSM-5 Dimensions of Psychosis Symptom Severity: Understanding Treatment Response in Patients with Schizophrenia
    Kalali, A.
    Siu, C.
    Cucchiaro, J.
    Pikalov, A.
    Goldman, R.
    Grossman, F.
    Loebel, A.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S388 - S388
  • [8] CLINICAL UTILITY OF A DIMENSIONAL APPROACH TO RATING SEVERITY FOR THE CORE SYMPTOMS OF PSYCHOSIS IN DSM-5: FACTOR STRUCTURE FOR EARLY PSYCHOSIS
    Lee, Kyuyoung
    Jeong, Jae Hoon
    Chung, Young Chul
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S280 - S281
  • [9] Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale
    Loebel, A.
    Schooler, N.
    Siu, C.
    Cucchiaro, J.
    Pikalov, A.
    Goldman, R.
    Grossman, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S518 - S518
  • [10] Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale
    Loebel, A.
    Schooler, N.
    Siu, C.
    Cucchiaro, J.
    Pikalov, A.
    Goldman, R.
    Grossman, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S491 - S491
12